sur Onco-Innovations Limited (CVE:ONCO)
Onco-Innovations Subsidiary Files Provisional Patent for AI Platform SynoGraph
Onco-Innovations Limited's subsidiary, Inka Health, has filed a provisional patent application with the USPTO for its new AI platform, SynoGraph. This platform uses AI-driven causal inference to enhance precision medicine by identifying cancer patients likely to respond to treatments. The patent application, filed on January 28, 2025, is a significant step in safeguarding their innovative technology.
SynoGraph integrates diverse medical data like genomics and proteomics to optimize treatment decisions and clinical trial design. It aims to streamline trial design and patient selection, potentially shortening trial timelines and reducing development costs.
Dr. Paul Arora, CEO of Inka Health, emphasized the importance of protecting their AI technology to bolster their position in healthcare technology.
R. P.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de Onco-Innovations Limited